Long-Term Efficacy of Systemic Multiexon Skipping Targeting Dystrophin Exons 45–55 With a Cocktail of Vivo-Morpholinos in Mdx52 Mice

Published 2015 View Full Article

Authors

Keywords

antisense therapeutics, Duchenne muscular dystrophy, dystrophin, mdx52, mouse, multiexon skipping, Vivo-Morpholinos

Journal

Molecular Therapy-Nucleic Acids

Volume 4, Issue -, Pages e225

Publisher

Elsevier BV

Online

2015-02-04

DOI

10.1038/mtna.2014.76

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now